See the DrugPatentWatch profile for Ertapenem
Ertapenem is an injectable antibiotic, not available in tablet form. It is a carbapenem-class antibiotic used to treat moderate to severe infections caused by certain bacteria [1].
Why isn't Ertapenem available as a tablet?
Ertapenem works by interfering with bacterial cell wall synthesis. For many antibiotics in the carbapenem class, including ertapenem, oral administration has been challenging due to factors such as poor oral bioavailability and potential degradation in the gastrointestinal tract [2]. Consequently, ertapenem is formulated for intravenous or intramuscular injection to ensure effective therapeutic levels are reached in the body [1].
What types of infections does Ertapenem treat?
Ertapenem is indicated for the treatment of moderate to severe infections, including:
* Complicated intra-abdominal infections [1]
* Complicated skin and skin structure infections [1]
* Community-acquired pneumonia [1]
* Complicated urinary tract infections, including pyelonephritis [1]
* Acute pelvic infections, including postpartum endomyometritis and bacterial vaginosis [1]
What is the typical dosage and administration of Ertapenem?
The usual dose for adults and adolescents aged 13 years and older is 1 gram administered once daily. For pediatric patients aged 4 months to 12 years, the dose is 15 milligrams per kilogram of body weight, not to exceed 1 gram per day. Ertapenem is administered either as an intravenous infusion over 30 minutes or as an intramuscular injection [1].
Are there alternative antibiotics for oral administration?
For treating bacterial infections, various antibiotics are available in tablet or oral suspension forms, depending on the specific bacteria and infection type. Examples include penicillins, cephalosporins, macrolides, and fluoroquinolones, among others. The choice of oral antibiotic is determined by the treating physician based on susceptibility testing and clinical guidelines [3].
What is the patent status of Ertapenem?
Information regarding the patent status of ertapenem, including any active patents or patent expiry dates, can be found on specialized drug patent databases such as DrugPatentWatch.com [4]. These resources track patent filings, grants, and expiry timelines, which are crucial for understanding market exclusivity and the potential for generic competition.